Battle Richard K, Henderson Lorna, Phelan Paul J, Latham Katy, Turner David M
Histocompatibility and Immunogenetics Department, Scottish National Blood Transfusion Service, Edinburgh, UK.
Department of Renal Medicine, Royal Infirmary of Edinburgh, Edinburgh, UK.
HLA. 2020 Jul;96(1):76-82. doi: 10.1111/tan.13913. Epub 2020 May 12.
Recent reports have identified that the presence of non-native conformation HLA to which antibody can bind upon Luminex HLA Class I single antigen beads, can vary in levels between different manufacturers kits and that the prozone effect may also be specific to particular products. We present a case in which both prozone and non-native HLA reactive antibodies were observed, which raises important questions on how SAB assays are utilised, especially in the post-transplant monitoring setting. A 56-year old, highly sensitised female patient awaiting a regraft received a HLAi renal transplant. Post-transplant monitoring showed discordant results between two SAB manufacturers assays, with one assay identifying a potential de novo HLA DSA. HLA Class I antibody reactivity was observed which was directed towards the Bw6 public epitope, which is present upon HLA molecules encoded for by numerous HLA-B alleles. However in the day 19 post-transplant sample reactivity spread beyond the Bw6 epitope. To investigate the possibility of a prozone type effect influencing the testing kit the day 19 post-transplant sample was diluted 1:10 with PBS and reanalysed. After dilution the Bw6 reactivity was observed again, however the suspect de novo DSA still persisted. An analysis of the mismatched epitopes identified one manufacturer's assay as being confounded by the presence of denatured reactivity as well as prozone.
最近的报告指出,在Luminex HLA I类单抗原微珠上存在可与抗体结合的非天然构象HLA,其水平在不同制造商的试剂盒之间可能有所不同,而且前带效应也可能特定于特定产品。我们报告了一个同时观察到前带和非天然HLA反应性抗体的病例,这引发了关于如何使用特异性抗体检测(SAB)分析的重要问题,尤其是在移植后监测环境中。一名56岁、高度致敏的女性患者在等待再次移植时接受了HLAi肾移植。移植后监测显示,两家SAB制造商的检测结果不一致,其中一项检测发现了潜在的新生HLA供体特异性抗体(DSA)。观察到针对Bw6公共表位的HLA I类抗体反应性,该表位存在于由众多HLA - B等位基因编码的HLA分子上。然而,在移植后第19天的样本中,反应性超出了Bw6表位。为了研究前带效应影响检测试剂盒的可能性,将移植后第19天的样本用磷酸盐缓冲液(PBS)按1:10稀释并重新分析。稀释后再次观察到Bw6反应性,但可疑的新生DSA仍然存在。对错配表位的分析表明,一家制造商的检测受到变性反应性以及前带的影响。